Polyoma virus complementary RNA directs the in vitro synthesis of capsid proteins VP1 and VP2.
Polyoma virus complementary RNA, synthesized in vitro by using highly purified Escherichia coli RNA polymerase and nondefective form I polyoma DNA, was translated in a wheat germ cell-free system. Polypeptides were synthesized that comigrated on sodium dodecyl sulfate-polyacrylamide gels with the polyoma capsid proteins VP1 and VP2, although most of the cell-free products were of smaller molecular weights. The VP1-size protein specifically immunoprecipitated with anti-polyoma virus serum, and upon digestion by trypsin yielded [35S]methionine-labeled tryptic peptides that co-chromatographed with the [3H]methionine-labeled tryptic peptides of virion-derived VP1 on both cation-exchange and anion-exchange resins. The VP2-size in vitro product contained all the virion VP2 methionine-labeled tryptic peptides, as shown by cation- and anion-exchange chromatography and two-dimensional fingerprinting on cellulose. We conclude that full-length polyoma VP1 and VP2 are synthesized in response to complementary RNA and consequently that the viral capsid proteins VP1, VP2, and VP3 are entirely virus coded.
D002213:Capsid / Q000096:biosynthesis*; D002474:Cell-Free System; D002852:Chromatography, Ion Exchange; D004279:DNA, Viral / Q000378:metabolism; D012321:DNA-Directed RNA Polymerases / Q000378:metabolism; D004926:Escherichia coli / Q000201:enzymology; D008970:Molecular Weight; D010452:Peptide Biosynthesis; D011120:Polyomavirus / Q000378:metabolism*; D014176:Protein Biosynthesis; D012367:RNA, Viral / Q000096:biosynthesis / Q000378:metabolism*; D014764:Viral Proteins / Q000096:biosynthesis*
D004279:DNA, Viral; D012367:RNA, Viral; D014764:Viral Proteins; D012321:DNA-Directed RNA Polymerases